MARAVAI LIFESC.HLD.A -01 Price, Chart & Factor Analysis
Free Data & Analytics AccessMARAVAI LIFESC.HLD.A -01 Forecast
MARAVAI LIFESC.HLD.A -01 short-term momentum is negative (up over 1 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term SELL signal. The long-term trend is neutral (4 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term NEUTRAL signal. Based on 20-day realised volatility of 72.7% a year, a typical one-standard-deviation range is 5.6745–6.9695 over a week, 4.9950–7.6490 over a month and 1.7253–10.92 over a year. (Signals as of 22 Nov 2026.)
MARAVAI LIFESC.HLD.A -01 Price Chart
MARAVAI LIFESC.HLD.A -01 Factors
Research on MARAVAI LIFESC.HLD.A -01
Explore MacroFinance macro & markets research and analysis.
MARAVAI LIFESC.HLD.A -01 Trading Strategies
9 backtested tactical asset allocation strategies hold VGK (European market), the closest tradable exposure to MARAVAI LIFESC.HLD.A -01; 1 of them are invested now. Strategies currently invested are listed first.
| Strategy | Style | Rebalance | Now in VGK | CAGR | Sharpe | Max DD |
|---|---|---|---|---|---|---|
| Adaptive Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Keuning's Defensive Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Keuning's Protective Asset Allocation - CPR | Moderate | Monthly | Premium · upgrade to view | |||
| Financial Mentor's Optimum3 | Moderate | Monthly | Premium · upgrade to view | |||
| Wouter Keller's Bold Asset Allocation - Balanced | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Keuning's Protective Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Keller and Keuning's Vigilant Asset Allocation - Balanced | Moderate | Monthly | Premium · upgrade to view | |||
| Ilya Kipnis' Defensive Adaptive Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Keuning and Keller's Generalized Protective Momentum | Moderate | Monthly | Premium · upgrade to view | |||
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
Statistical Distribution of Returns
PlusHow MARAVAI LIFESC.HLD.A -01’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About MARAVAI LIFESC.HLD.A -01 (Germany)
MARAVAI LIFESC.HLD.A -01 is a listed security in Germany. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
More on MARAVAI LIFESC.HLD.A -01
Frequently asked questions
What is MARAVAI LIFESC.HLD.A -01?
What is the latest MARAVAI LIFESC.HLD.A -01 price?
Is MARAVAI LIFESC.HLD.A -01 in an uptrend?
How volatile is MARAVAI LIFESC.HLD.A -01?
What factors affect MARAVAI LIFESC.HLD.A -01?
Which trading strategies trade MARAVAI LIFESC.HLD.A -01?
How are MARAVAI LIFESC.HLD.A -01 returns analysed?
Where can I download free MARAVAI LIFESC.HLD.A -01 historical data?
Free MARAVAI LIFESC.HLD.A -01 historical data (last 10 years)
Browse or instantly download the last 10 years of MARAVAI LIFESC.HLD.A -01 daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.MAR.F&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 6.322 |
| 2026-11-19 | 6.56 |
| 2026-11-18 | 6.623 |
| 2026-11-17 | 6.59 |
| 2026-11-16 | 6.651 |
| 2026-11-13 | 6.76 |
| 2026-11-12 | 6.877 |
| 2026-11-11 | 6.999 |
| 2026-11-10 | 6.948 |
| 2026-11-09 | 7.053 |
About this stock
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS. The TRILINK segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, and oligonucleotide therapy, as well as molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, CleanCap capping technology-based oligonucleotide building blocks, and custom enzyme development and manufacturing; and research products for labeling and detecting proteins in cells and tissue samples. The CYGNUS segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, and antibody-based products to detect impurities during the production of biopharmaceutical products. It serves biopharmaceutical companies, and emerging biopharmaceutical and life sciences research companies; and academic research institutions and diagnostics companies. Maravai LifeSciences Holdings, Inc. was founded in 2014 and is headquartered in San Diego, California.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.